Santhosh Palani
Fortune : 25 786 $ au 31/05/2026
Fortune : 25 786 $ au 31/05/2026
Santhosh Palani is the founder of PSP Research LLC, founded in 2024, holding the title of Managing Member & CMP.
Current jobs include Independent Director at Pyxis Oncology, Inc. since 2024 and Independent Director at Acrivon Therapeutics, Inc. since 2024.
Former jobs include Associate Director-Oncology Clinical Development at Pfizer Inc. from 2013 to 2016, Director at Metagenomi Therapeutics, Inc. from 2022 to 2024, Scientist at Millennium Pharmaceuticals, Inc. from 2012 to 2013, Vice President-Biotechnology Equity Research at Cowen & Co. LLC from 2016 to 2018, Principal at NEA Management Co. LLC from 2018 to 2020, Partner at PFM Health Sciences LP from 2020 to 2024, Research Scientist at Columbia University Irving Medical Center from 2010 to 2012, and roles as Independent Director at Caribou Biosciences, Inc., Director at Metagenomi Technologies LLC, Director at Turnstone Biologics Corp., and Principal at New Enterprise Associates LLC.
Education includes a doctorate from the University of Pennsylvania conferred in 2010, graduate studies at Texas A&M University, and undergraduate studies at the University of Madras.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/05/2026 | 9 366 ( 0,02 % ) | 14 986 $ | 31/05/2026 | |
PYXIS ONCOLOGY, INC. 0,01 % | 20/04/2026 | 6 000 ( 0,01 % ) | 10 800 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/03/2024 |
| PYXIS ONCOLOGY, INC. | Directeur/Membre du Conseil | 12/03/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| METAGENOMI THERAPEUTICS, INC. | Directeur/Membre du Conseil | 17/01/2024 |
PFM Health Sciences LP
PFM Health Sciences LP Investment ManagersFinance PFM generally uses bottom-up analysis in an attempt to identify transformational changes, trends, investment themes and core investment opportunities across asset classes and geographies. Their investment strategies are currently (1) Healthcare, which primarily invests in the global healthcare industry, (2) Growth Equity, which primarily invests in growth equity healthcare investments and (3) Biotech Opportunities, which primarily invests in biotech investments. The firm utilizes certain co-investment vehicles from time to time for investment opportunities in privately held companies. | Corporate Officer/Principal | 01/01/2024 |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements. | Private Equity Investor | 01/05/2020 |
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/05/2018 |
| PFIZER INC. | Corporate Officer/Principal | 01/01/2016 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 16 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
PFM Health Sciences LP
PFM Health Sciences LP Investment ManagersFinance PFM generally uses bottom-up analysis in an attempt to identify transformational changes, trends, investment themes and core investment opportunities across asset classes and geographies. Their investment strategies are currently (1) Healthcare, which primarily invests in the global healthcare industry, (2) Growth Equity, which primarily invests in growth equity healthcare investments and (3) Biotech Opportunities, which primarily invests in biotech investments. The firm utilizes certain co-investment vehicles from time to time for investment opportunities in privately held companies. | Finance |
Caribou Biosciences, Inc.
Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements. | Finance |
Texas A&M University
Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Madras
University of Madras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University Medical Center
Columbia University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Enterprise Associates LLC
New Enterprise Associates LLC Investment ManagersFinance Operates as a venture capital firm | Finance |
Turnstone Biologics Corp.
Turnstone Biologics Corp. BiotechnologyHealth Technology Develops and sells medicines to treat and cure solid tumors | Health Technology |
Pyxis Oncology, Inc.
Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
Metagenomi Technologies LLC
Metagenomi Technologies LLC BiotechnologyHealth Technology Develops genetic medicines using metagenomics-powered genome editing toolbox | Health Technology |
Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Metagenomi, Inc.
Metagenomi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a genetic medicines company that develops curative therapeutics for patients | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national